OSI-7904L

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameOSI-7904L
Drug Alias NameBW-1843U89OSI-7904LGS-7904LOVI-237GW-1843U89 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead IncOncovista Innovative Therapies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncOsi Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsSolid tumoursHead and Neck NeoplasmsStomach Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank